| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/20/2006 | EP1701723A2 Colon cleansing composition and method |
| 09/20/2006 | EP1432792B1 Histone deacetylase 9 |
| 09/20/2006 | EP1392363B1 Use of mGLuR5 antagonists in the manufacture of a medicament in the treatment of Fragile X syndrome, Autism and Mental Retardation |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1280897B1 Regulation of nf-at interacting protein nip 45 variant |
| 09/20/2006 | EP1272530B1 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 09/20/2006 | EP1272188B1 Use of egfr tyrosine kinase inhibitors for treating brest cancer |
| 09/20/2006 | EP1246841B1 Transcription factors containing two potential dna binding motifs |
| 09/20/2006 | EP1218049B1 Apparatus for relieving headaches, rhinitis and other common ailments |
| 09/20/2006 | EP1079875B1 Cancer treatment by ultrapheresis removing compounds of less than 120,000 daltons |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | EP0799037B1 Compositions for treating allergic rhinitis and other disorders comprising descarboethoxyloratadine |
| 09/20/2006 | CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein |
| 09/20/2006 | CN1835942A Mucin synthesis inhibitors |
| 09/20/2006 | CN1835765A Method of treating viral infections |
| 09/20/2006 | CN1835759A Micronutrient supplement |
| 09/20/2006 | CN1835755A Gsk－3抑制剂及其用途 Gsk-3 inhibitors and their use |
| 09/20/2006 | CN1835752A Multivitamin syrup for children or young adults |
| 09/20/2006 | CN1835741A Novel composition comprising rosiglitazone and another antidiabetic agent |
| 09/20/2006 | CN1835735A Drug delivery system for administering fine particle under tenon's capsule |
| 09/20/2006 | CN1833636A Application of biphenyl cyclooctadiene lignin in treatment of tumour medicine |
| 09/20/2006 | CN1276549C Apparatus for a quick release safety connector assembly |
| 09/20/2006 | CN1275977C O-aryl glucoside SGL T2 inhibitors |
| 09/20/2006 | CN1275965C Derivatives of variolin b |
| 09/20/2006 | CN1275962C Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 09/19/2006 | US7110650 Method for configuring air-core photonic-bandgap fibers free of surface modes |
| 09/19/2006 | US7109329 Side effect reduction; muscular disorders; trauma |
| 09/19/2006 | US7109301 Tenascin-C isoform as marker for neoplasias |
| 09/19/2006 | US7109299 Peptides of sequence of amino acids where one or more of the peptidyl [ C(O)NR ] linkages (bonds) have been replaced by a non-peptidyl linkage; IL-5 antagonists treating asthma |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109291 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 09/19/2006 | US7109235 Microtubule stabilizing compounds |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109207 Used to treat metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109198 Method for treating obesity |
| 09/19/2006 | US7109196 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7109184 Phosphate transport inhibitors |
| 09/19/2006 | US7109183 Phosphohalohydrins, process for the production thereof and use thereof |
| 09/19/2006 | US7109181 Administering to a subject a purinergic receptor agonist in an amount therapeutically effective to alter the amount or formulation of synovial fluids |
| 09/19/2006 | US7109179 Methods and compositions comprising DNA damaging agents and p53 |
| 09/19/2006 | US7109171 Reducing FSH levels by administering a GnRH antagonist to reduce both plasma FSH and LH levels; treating prostatic intraepithelial neoplasia, pedophilia, infertility, vaginal bleeding; in vitro fertilization and male contraception |
| 09/19/2006 | US7109164 Administering compounds such as 3-[[3,5-dibromo-[4-hydroxy-3-(1-methylethyl)phenoxy]-phenyl]amino]-3-oxopropanoic acid for therapy of obesity, hypercolesterolemia atherosclerosis, depression, osteoporosis, hypothyroidism, goiter, glaucoma, cardiac arrhythmia, congestive heart failure, or a skin disorder |
| 09/19/2006 | US7109163 For use in hemostatic devices that are suitable for applying a flowable hemostatic formulation to a site requiring hemostasis |
| 09/19/2006 | US7109027 Aβ-Peptide screening assay |
| 09/19/2006 | US7108869 For limiting the absorption of carbohydrates contained in a foodstuff, for promoting weight loss in an individual |
| 09/19/2006 | US7108857 Therapy for injured muscles |
| 09/19/2006 | US7108847 Delivery of muscle relaxants through an inhalation route |
| 09/19/2006 | CA2083493C Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 09/14/2006 | WO2006096434A2 Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders |
| 09/14/2006 | WO2006095897A1 Screening method |
| 09/14/2006 | WO2006095870A1 Photosensitizer, protein-cleaving agent, method of cleaving protein, sugar molecule-cleaving agent, method of cleaving sugar molecule, and photodynamic therapeutic agent |
| 09/14/2006 | WO2006095822A1 Sulfonamide compound and pharmaceutical thereof |
| 09/14/2006 | WO2006095559A1 USE OF Fgf21 AS HEMATOPOIETIC FACTOR |
| 09/14/2006 | WO2006095270A1 Combination anticancer therapy or om-174 and pharmaceutical compositions therefor |
| 09/14/2006 | WO2006095259A2 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds |
| 09/14/2006 | WO2006095095A1 Ophthalmologic compositions and use mode thereof |
| 09/14/2006 | WO2006095074A1 Anti-smoking composition |
| 09/14/2006 | WO2006094971A1 Combination of interleukin-6 antagonists and antiproliferative drugs |
| 09/14/2006 | WO2006094703A1 Use of an antagonist of epac for treating human cardiac hypertrophy |
| 09/14/2006 | WO2006086445A3 Combination therapy |
| 09/14/2006 | WO2006077427A3 Antiviral drug combinations |
| 09/14/2006 | WO2006009465A3 Composition comprising protein material and non-oxidizable fatty acid entities |
| 09/14/2006 | WO2005105120A3 Pharmaceutical combination, active on central nervous system (cns) and set of pharmaceuticals; method of treatment of cns-disorders; means facilitating penetration of the hematoencephalic barrier; pharmaceutical means for endonasal administration |
| 09/14/2006 | WO2005084710B1 Nanocell drug delivery system |
| 09/14/2006 | US20060205931 Pharmaceutical compositions having appetite suppressant activity |
| 09/14/2006 | US20060205814 Administering mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester; cardiovascular disorders; administered along with ACE-, NEP-, or phosphodiesterase inhibitors; diuretics, positive inotropic drugs, vasodilators, beta-blockers, digitalis glycosides |
| 09/14/2006 | US20060205809 Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 09/14/2006 | US20060205806 Synergistic combination |
| 09/14/2006 | US20060205795 Cancer treatment with epothilones |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205723 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/14/2006 | US20060205702 Combinations comprising antimuscarinic agents and corticosteroids |
| 09/14/2006 | US20060205696 [[2-(Amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 09/14/2006 | US20060205691 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 09/14/2006 | US20060205686 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/14/2006 | US20060205675 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus |
| 09/14/2006 | US20060205672 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205658 Irrigation solution and method for inhibition of pain and inflammation |
| 09/14/2006 | US20060205657 Irrigation solution and method for inhibition of pain and inflammation |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205650 Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors |
| 09/14/2006 | US20060205634 Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease |
| 09/14/2006 | US20060205633 Therapeutic agent for diabetes |
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060204982 Novel compositions and methods for cancer |
| 09/14/2006 | US20060204592 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions |
| 09/14/2006 | US20060204587 Use of film coating as taste-masking coating of oral dosage forms |
| 09/14/2006 | US20060204518 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 09/14/2006 | US20060204517 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 09/14/2006 | US20060204510 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 09/14/2006 | US20060204489 Protein C derivatives |
| 09/14/2006 | US20060204459 Use of tyrosine inhibitors for whitening human skin and treating melanocyted dysfunction associated diseases |
| 09/14/2006 | CA2600636A1 New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors |
| 09/14/2006 | CA2600350A1 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 09/14/2006 | CA2599783A1 Use of an antagonist of epac for treating human cardiac hypertrophy |
| 09/14/2006 | CA2598503A1 New ophthalmologic compositions and their method of use |